How we reduced polypharmacy by 1.6 medicines per patient in a care home A pharmacist-led study revealed statistical significance in the reduction of medicines and anticholinergic burden, following structured medication reviews in care home patients.…
Pharmacists cut medication errors and costs on diabetes and endocrinology wards, study results show The number of reported medication incidents decreased by 100% during the eight-week study period.…
Prescribing dilemma: angiotensin-converting enzyme inhibitors for heart failure in an older patient The fourth article of our new prescribing dilemmas series, exploring real-world dilemmas that pharmacist prescribers encounter in clinical practice.…
Adrenal insufficiency: pathophysiology, diagnosis and management Patients with adrenal insufficiency are at risk of life-threatening adrenal crises. It is vital that pharmacists know how to treat this rare condition appropriately.…
Prescribing dilemma: balancing risk and benefit when treating sertraline sexual dysfunction The first of a new series of articles exploring real-world dilemmas that pharmacist prescribers encounter in clinical practice.…
Less is more: the struggle to prioritise structured medication reviews With primary care networks no longer incentivised to carry out structured medication reviews, work is under way to make sure they remain a priority as pharmacists aim to minimise inappropriate polypharmacy.…
A campaign to help patients discuss their medicines nearly doubled our medication reviews The ‘Me and My Medicines’ campaign distributes information in nine languages to encourage Black and minority ethnic groups to raise concerns about their medicines.…
Reconciling medicine review targets with hospital workforce challenges As hospital workforce pressures bite, pharmacy teams are questioning whether medicines reconciliation targets are appropriate.…
Structured medication reviews increase in primary care despite end of financial incentive Exclusive: Analysis of NHS England data show there was a 15% increase in structured medication reviews in the 2023/2024 financial year up to February 2024, compared with the year before.…
Learning and CPD: 2023 in review Here, we look back on some of the highlights from research and learning content published in 2023 by The Pharmaceutical Journal and celebrate the valuable contributions made by our expert authors and reviewers.…
